<!doctype html>
<html lang="en">
  <head>
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    <title>Bootstrap demo</title>
    <link href="https://cdn.jsdelivr.net/npm/bootstrap@5.3.3/dist/css/bootstrap.min.css" rel="stylesheet" integrity="sha384-QWTKZyjpPEjISv5WaRU9OFeRpok6YctnYmDr5pNlyT2bRjXh0JMhjY6hW+ALEwIH" crossorigin="anonymous">
  </head>
  <body class="container bg-light">

<div class="card">
<div class="lip-article custom-style-big-width custom-style-hide"><p><strong><span style="color: #228822;">Gapping up <br/> </span>In reaction to earnings/guidance</strong>: </p><ul><li><b>MNDY</b> +22%, 
<b>ROK</b> +7.7%, 
<b>ROIV</b> +3.6%, 
<b>MCD</b> +2.7%, 
<b>ASX</b> +1.6% (Jan revs),
<b>TSM</b> +1.2% (Jan revs)</li></ul><p><strong>Other news</strong>: </p><ul><li><b>AXSM</b> +11.6% (entered into a settlement agreement with Teva Pharmaceuticals resolving all patent litigation related to Axsome's AUVELITY product)</li><li><b>BOOM</b> +7.7% (Steel Connect disclosed after the close a 9.9% active stake; sent revises proposal to acquire shares for $10.18 per Share in cash; DMC Global acknowledged receipt of a non-binding proposal from Steel Connect to acquire all of the outstanding shares of common stock of the Company, not already owned by Steel Connect, for $10.18 per share in cash)
</li><li><b>X</b> +4.6% (Ancora Issues Letter to U.S. Steel's Board of Directors Following Failed Attempts to Resurrect the Dead Nippon Transaction)
</li><li><b>MATW</b> +4.2% (Issues Statement Following ISS Report)
</li><li><b>FDMT</b> +3.7% (presents 52-Week Results from Phase 2b Cohort of PRISM Wet AMD Study and Long-term Durability Data Supporting 4D-150 4FRONT Global Registration Program)
</li><li><b>LMND</b> +2.9% (amended customer investment agreement)
</li><li><b>PLYA</b> +2.8% (to be acquired by Hyatt (H) in all-cash transaction for $13.50 per share)
</li><li><b>ARAY</b> +2.1% (discloses in SEC filing that Leonel Peralta has been appointed as Senior Vice President, Chief Operations Officer, effective February 3, 2025)
</li><li><b>NOK</b> +1.9% (CEO to step down; names Justin Hotard as successor)
</li><li><b>LDI</b> +1.8% (unanimous jury returned a verdict in favor of loanDepot regarding the remaining claims in the litigation)
</li><li><b>INMB</b> +1.8% (intent to submit a BLA in the US and Marketing Authorization Application in the UK and EU supported by data from the MissionEB clinical trial investigating CORDStrom as a disease-modifying therapy for treating RDEB in pediatric patients)
</li><li><b>EL</b> +1.7% (Director bought 87000 shares at various prices from $64.57-68.80 worth ~$5724K)
</li><li><b>KOS</b> +1.7% (reports first LNG at GTA Project)
</li><li><b>RUM</b> +1.6% (Closes $775 Million Strategic Investment from Tether and Related Tender Offer)
</li><li><b>TEVA</b> +1.4% (files mixed shelf securities offering)
</li><li><b>NTRA</b> +1.1% (commented on recent updates by the NCCN on circulating tumor DNA molecular residual disease testing in the Clinical Practice Guidelines in Oncology for colon cancer, rectal cancer, and merkel cell carcinoma)
</li><li><b>BTBT</b> +1% (Monthly Production Update for January 2025)
</li><li><b>BA</b> +0.8% (report it plans to layoff 400 workers on moon rocket program, according to Bloomberg)
Â </li></ul>
<p><strong><span style="color: #ff0000;">Gapping down<br/> </span>In reaction to earnings/guidance</strong>: </p><ul><li><b>SMTC</b> -29.2% (guidance),
<b>EPC</b> -5.7%, 
<b>HAIN</b> -3.2%, 
L -1.8%, 
<b>WEC</b> -1% (guidance) </li></ul><p><strong>Other news</strong>: </p><ul><li><b>PLRX</b> -62.3% (pauses enrollment and dosing in the BEACON-IPF Phase 2b trial)
</li><li><b>SMHI</b> -11.3% (files for $200 mln mixed securities shelf offering)
</li><li><b>SCHW</b> -3.3% (commences secondary offering of its common stock through which TD Group US Holdings, an affiliate of The Toronto-Dominion Bank (TD), intends to exit its full investment in the Company)
</li><li><b>SNCY</b> -3% (launch of secondary public offering of common stock and concurrent share repurchase)</li><li><b>RR</b> -2.9% (files for $200 mln mixed securities shelf offering)
</li><li><b>AZPN</b> -2.7% (Emerson issues statement at launch of AspenTech (AZPN) tender offer - $265 per share in cash, unanimously recommended by the independent AspenTech Special Committee)
</li><li><b>IDYA</b> -2.5% (new CFO)
</li><li><b>GLSI</b> -2.3% (provides update on open label HLA data from FLAMINGO-01)
</li><li><b>CX</b> -1.8% (names new CEO)
</li></ul></div>
</div>

    <script src="https://cdn.jsdelivr.net/npm/bootstrap@5.3.3/dist/js/bootstrap.bundle.min.js" integrity="sha384-YvpcrYf0tY3lHB60NNkmXc5s9fDVZLESaAA55NDzOxhy9GkcIdslK1eN7N6jIeHz" crossorigin="anonymous"></script>
  </body>
</html>